Viewing Study NCT01856634


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-26 @ 1:07 AM
Study NCT ID: NCT01856634
Status: COMPLETED
Last Update Posted: 2018-01-30
First Post: 2013-05-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module